Search by Drug Name or NDC
NDC 53002-1521-00 DILTIAZEM HYDROCHLORIDE 180 mg/1 Details
DILTIAZEM HYDROCHLORIDE 180 mg/1
DILTIAZEM HYDROCHLORIDE is a ORAL CAPSULE, EXTENDED RELEASE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by RPK Pharmaceuticals, Inc.. The primary component is DILTIAZEM HYDROCHLORIDE.
MedlinePlus Drug Summary
Diltiazem is used to treat high blood pressure and to control angina (chest pain). Diltiazem is in a class of medications called calcium-channel blockers. It works by relaxing the blood vessels so the heart does not have to pump as hard. It also increases the supply of blood and oxygen to the heart. High blood pressure is a common condition, and when not treated it can cause damage to the brain, heart, blood vessels, kidneys, and other parts of the body. Damage to these organs may cause heart disease, a heart attack, heart failure, stroke, kidney failure, loss of vision, and other problems. In addition to taking medication, making lifestyle changes will also help to control your blood pressure. These changes include eating a diet that is low in fat and salt, maintaining a healthy weight, exercising at least 30 minutes most days, not smoking, and using alcohol in moderation.
Related Packages: 53002-1521-00Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Diltiazem
Product Information
| NDC | 53002-1521 |
|---|---|
| Product ID | 53002-1521_121c828a-e698-4176-a8c5-6b8eb5a150d5 |
| Associated GPIs | |
| GCN Sequence Number | n/a |
| GCN Sequence Number Description | n/a |
| HIC3 | n/a |
| HIC3 Description | n/a |
| GCN | n/a |
| HICL Sequence Number | n/a |
| HICL Sequence Number Description | n/a |
| Brand/Generic | n/a |
| Proprietary Name | DILTIAZEM HYDROCHLORIDE |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | DILTIAZEM HYDROCHLORIDE |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | CAPSULE, EXTENDED RELEASE |
| Route | ORAL |
| Active Ingredient Strength | 180 |
| Active Ingredient Units | mg/1 |
| Substance Name | DILTIAZEM HYDROCHLORIDE |
| Labeler Name | RPK Pharmaceuticals, Inc. |
| Pharmaceutical Class | Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A4 Inhibitors [MoA] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA074943 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 53002-1521-00 (53002152100)
| NDC Package Code | 53002-1521-0 |
|---|---|
| Billing NDC | 53002152100 |
| Package | 100 CAPSULE, EXTENDED RELEASE in 1 BOTTLE (53002-1521-0) |
| Marketing Start Date | 2018-10-01 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |